Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: Feasibility and preliminary results
D. Elias et al., Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: Feasibility and preliminary results, HEP-GASTRO, 46(25), 1999, pp. 360-363
BACKGROUND/AIMS: Peritoneal carcinomatosis (PC) discovered during hepatecto
my is usually a contraindication to resection. A potentially efficient trea
tment of PC is the resection of the macroscopic disease and the treatment o
f the residual microscopic disease with immediate postoperative intraperito
neal chemotherapy (IPIC) (before the entrapment of cancer cells inside the
fibrin deposit which rapidly cover the injured tissues). Feasibility and su
rvival results of this treatment, combined with major hepatectomy, have nev
er been evaluated. The purpose of this study is to report tolerance and pre
liminary results in patients with liver metastases synchronous to moderate
PC, treated with hepatectomy, complete cytoreductive surgery, and IPIC.
METHODOLOGY: Twelve patients with liver metastases and moderate PC from mis
cellaneous origins, underwent: 1) hepatectomy (9 of them were major hepatec
tomies); 2) complete cytoreductive surgery of the PC resecting between 20 a
nd 150 nodules; and, 3) IPIC, for 5 days, according to histology.
RESULTS: There was no mortality. Morbidity was mainly due to four transient
biliary leakages (33%) and there was no systemic complication due to the c
hemotherapy. After a median follow-up of 14.4 months, there was no detectab
le recurrence of the PC. Preliminary results concerning survival are promis
ing with 7 patients without recurrent disease.
CONCLUSIONS: When a minimal or moderate PC is discovered during laparotomy
for liver resection of metastases, the combination of hepatectomy with comp
lete cytoreductive surgery of the peritoneal disease, followed with IPIC is
logical and feasible. This aggressive treatment is well tolerated although
the frequency of biliary leakage seems to be higher than that after standa
rd hepatectomy. No recurrence of the peritoneal disease was detected and su
rvival results are very promising.